Jatin Roper, MD

Assistant Professor of Medicine
Assistant Professor in Pharmacology and Cancer Biology
Member of the Duke Cancer Institute
Campus mail 905 S. Lasalle Street, Gsrb-1, Room 1033, Durham, NC 27710
Phone (919) 660-2923
Email address jatin.roper@duke.edu

My laboratory is interested in understanding the molecular mechanisms of stem cell function in the normal intestine and in colorectal cancer using innovative three-dimensional organoid and in vivo platforms. We demonstrated that high fat diet-induced obesity activates peroxisome proliferator-activated receptor delta (PPARd) signaling in intestinal stem cells and progenitor cells, which increases stem cell regeneration and tumor initiation in the colon. We also pioneered novel orthotopic transplantation and in situ CRISPR/Cas9 gene editing models of colorectal cancer that recapitulate the adenoma-carcinoma-metastasis sequence. Research in the laboratory is focused on three main areas: 1) Immune regulation of the intestinal epithelium and colorectal cancer; 2) The effects of diet-induced obesity on regeneration in the intestine; and 3) analysis of colorectal cancer heterogeneity with single-cell mRNA sequencing and genetically engineered mouse models. The overall goal of this research is to develop new treatment approaches for intestinal diseases such as inflammatory bowel disease and colorectal cancer. I am also a gastroenterologist at Duke University Hospital and the Durham VA Hospital. My clinical interests include colorectal cancer screening and gastrointestinal cancer genetics.

Education and Training

  • Postdoctoral Fellow (mentor: Omer H. Yilmaz, M.D., PhD), Koch Institute for Integrative Cancer Research at MIT, 2014 - 2018
  • Postdoctoral Fellow in Gastroenterology and Hepatology, Tufts University School of Medicine, 2011 - 2014
  • Fellowship in Gastroenterology and Hepatology, Tufts University School of Medicine, 2008 - 2012
  • Residency in Internal Medicine, New York University School of Medicine, 2006 - 2008
  • Michael Saperstein Medical Scholar, New York University School of Medicine, 2005 - 2006
  • Internship in Internal Medicine, New York University School of Medicine, 2004 - 2005
  • M.D., Boston University School of Medicine, 2004


Sheahan, Breanna J., Ally N. Freeman, Theresa M. Keeley, Linda C. Samuelson, Jatin Roper, Stephanie Hasapis, Chang-Lung Lee, and Christopher M. Dekaney. “Epithelial Regeneration After Doxorubicin Arises Primarily From Early Progeny of Active Intestinal Stem Cells.” Cell Mol Gastroenterol Hepatol 12, no. 1 (2021): 119–40. https://doi.org/10.1016/j.jcmgh.2021.01.015.

Full Text

Cheung, Priscilla, Jordi Xiol, Michael T. Dill, Wei-Chien Yuan, Riccardo Panero, Jatin Roper, Fernando G. Osorio, et al. “Regenerative Reprogramming of the Intestinal Stem Cell State via Hippo Signaling Suppresses Metastatic Colorectal Cancer.” Cell Stem Cell 27, no. 4 (October 1, 2020): 590-604.e9. https://doi.org/10.1016/j.stem.2020.07.003.

Full Text

Han, Huajun, Laurie A. Davidson, Yang-Yi Fan, Jennifer S. Goldsby, Grace Yoon, Un-Ho Jin, Gus A. Wright, et al. “Loss of aryl hydrocarbon receptor potentiates FoxM1 signaling to enhance self-renewal of colonic stem and progenitor cells.” Embo J 39, no. 19 (October 1, 2020): e104319. https://doi.org/10.15252/embj.2019104319.

Full Text

Cheltsov, Anton, Natsuko Nomura, Venkata M. Yenugonda, Jatin Roper, Rajesh Mukthavaram, Pengfei Jiang, Nam-Gu Her, Ivan Babic, Santosh Kesari, and Elmar Nurmemmedov. “Allosteric inhibitor of β-catenin selectively targets oncogenic Wnt signaling in colon cancer.” Sci Rep 10, no. 1 (May 15, 2020): 8096. https://doi.org/10.1038/s41598-020-60784-y.

Full Text

Dangi, A., J. Wang, A. Joseph, J. Roper, N. Surana, and X. Luo. “A Mouse Model of Paratopic Intestinal Transplantation to Delineate GVHD-Free Alloimmune Rejection Responses.” In American Journal of Transplantation, 20:636–636, 2020.


Rickelt, Steffen, Charlene Condon, Miyeko Mana, Charlie Whittaker, Christina Pfirschke, Jatin Roper, Deepa T. Patil, et al. “Agrin in the Muscularis Mucosa Serves as a Biomarker Distinguishing Hyperplastic Polyps from Sessile Serrated Lesions.” Clin Cancer Res 26, no. 6 (March 15, 2020): 1277–87. https://doi.org/10.1158/1078-0432.CCR-19-2898.

Full Text